Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Clin Psychiatry. 2017 Jun;78(6):e656–e667. doi: 10.4088/JCP.16r11113

Table 2.

Controlled Trials of SAMe vs. Other Antidepressants

Trial Year Patients
enrolled
Experimental
Design
Duration
(days)
SAMe
dose
(mg/day)
Route Other
Antidepressant
Other dose
(mg/day)
Route Primary
Outcome
Measure
Relative Efficacy (SAMe vs. Other)
Total SAMe Other
Mantero et al.53 1975 31 16 15 double-blind 21 75 IM Imipramine 75 IM HAM-D SAMe = Other

Miccoli et al.54 1978 86 45 41 double-blind 21 200 IV Chlorimipramine or Amitryptyline 100 IV HAM-D SAMe = Other

Barberi et al.36 1978 20 10 10 double-blind 20 200 IV Amitriptyline 100 IV HAM-D P value for comparison not provideda

Del Vecchio et al.55 1978 28 14 14 double-blind 21 150 IV Chlorimipramine 100 IV HAM-D SAMe = Other

Scarzella et al.56,b 1978 20 10 10 double-blind 15 250 IV Chlorimipramine 100 IV HAM-D SAMe = Other

Calandra et al.57 1979 24 12 12 no blind 15 150 IV Chlorimipramine 100 IV HAM-D SAMe = Other

Monaco et al.58 1979 20 11 9 double-blind 15 200 IV Amitriptyline 100 IV HAM-D SAMe = Other

Scaggion et al.59 1982 40 22 18 double-dummy 15 300 IV Nomifensine 200 PO HAM-D SAMe = Other

Kufferle et al.60 1982 20 10 10 double-blind 18 150 IV Chlorimipramine 50 IV HAM-D SAMe = Other

Ubago et al.61 1984 30 15 15 double-blind 30 100 IV Chlorimipramine 50 PO HAM-D SAMe = Other

Bell et al.62,b 1988 22 11 11 double-dummy 14 400 IV Imipramine 150 PO HAM-D SAMe > Otherc

Janicak et al.43 1988 20 12 3 double-dummy 14 400 IV Imipramine 150 PO HAM-D SAMe = Other

Cerutti et al.63 1989 20 20 20 cross-over 21 800 PO Minaprine 200 PO HAM-D SAMe > Otherc

Bell et al.64 1990 28 14 14 double-blind 28 1600 PO Desipramine 250 PO HAM-D SAMe = Other

De Vanna et al.65,b 1992 30 15 15 double-blind 42 1600 PO Imipramine 140 PO MADRS P value for comparison not provideda

Bell et al.66 1994 17 11 6 double-blind 28 1600 PO Desipramine 250 PO HAM-D P value for comparison not provideda

Delle Chiale et al.50 1997 122 57 65 double-blind 21 800 IV Chlorimipramine 100 IV HAM-D Other > SAMed

Delle Chiale et al.67 2000 281 143 138 double-blind 42 1600 PO Imipramine 150 PO HAM-D SAMe = Other

Delle Chiale et al.67 2000 295 147 148 double-blind, dummy 28 400 IM Imipramine 150 PO HAM-D SAMe = Other

Pancheri et al.68 2002 293 146 147 double-blind 28 400 IM Imipramine 150 PO HAM-D SAMe = Other

Mischoulon et al.52 2014 189 64 65 double-blind, cross-over 84 1600-3200 PO Escitalopram 10-20 PO HAM-D SAMe = Other
a

Both groups demonstrated significant (p<0.05) improvements on primary outcome measure. P value for between-group comparison not provided.

b

SAMe-treated groups only. Significant (p<0.05) improvement by Day 10.

c

SAMe group demonstrated significant (p<0.05) improvement compared to other antidepressant group on primary outcome measure

d

Other antidepressant demonstrated significiant (p<0.05) improvement compared to SAMe on primary outcome measure

Abbreviations.

HAM-D, Hamilton Rating Scale for Depression

MADRS, Montgomery-Asberg's Rating Scale for Depression